These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 32458510)

  • 41. [Immunopathogenesis of invasive mould infections].
    García-Vidal C; Salavert Lletí M
    Rev Iberoam Micol; 2014; 31(4):219-28. PubMed ID: 25442381
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ibrutinib-Associated Leukocytoclastic Vasculitis in a Patient with Chronic Lymphocytic Leukemia.
    Kaya A; Aras İ; Özkan Kurtgöz P; Çakıroğlu U
    Turk J Haematol; 2024 Mar; 41(1):57-58. PubMed ID: 38433497
    [No Abstract]   [Full Text] [Related]  

  • 43. The current treatment landscape: other fungal diseases (cryptococcosis, fusariosis and mucormycosis).
    Lortholary O; Fernández-Ruiz M; Perfect JR
    J Antimicrob Chemother; 2016 Nov; 71(suppl 2):ii31-ii36. PubMed ID: 27880667
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Therapeutic Challenges of Non-
    Lamoth F; Kontoyiannis DP
    Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31481441
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Consensus guidelines for the diagnosis and management of invasive fungal disease due to moulds other than Aspergillus in the haematology/oncology setting, 2021.
    Bupha-Intr O; Butters C; Reynolds G; Kennedy K; Meyer W; Patil S; Bryant P; Morrissey CO;
    Intern Med J; 2021 Nov; 51 Suppl 7():177-219. PubMed ID: 34937139
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Current diagnosis and treatment of chronic lymphocytic leukaemia].
    Cramer P; von Tresckow J; Eichhorst B; Hallek M
    Dtsch Med Wochenschr; 2020 Aug; 145(16):1139-1144. PubMed ID: 32791549
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Invasive mold infections in lung and heart-lung transplant recipients: Stanford University experience.
    Vazquez R; Vazquez-Guillamet MC; Suarez J; Mooney J; Montoya JG; Dhillon GS
    Transpl Infect Dis; 2015 Apr; 17(2):259-66. PubMed ID: 25648194
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Diagnosis of non dermatophyte onychomycosis ant its relevance for treatment].
    Monod M; Lurati M; Baudraz-Rosselet F
    Rev Med Suisse; 2013 Apr; 9(380):730-3. PubMed ID: 23621043
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Early-onset invasive aspergillosis and other fungal infections in patients treated with ibrutinib.
    Ghez D; Calleja A; Protin C; Baron M; Ledoux MP; Damaj G; Dupont M; Dreyfus B; Ferrant E; Herbaux C; Laribi K; Le Calloch R; Malphettes M; Paul F; Souchet L; Truchan-Graczyk M; Delavigne K; Dartigeas C; Ysebaert L;
    Blood; 2018 Apr; 131(17):1955-1959. PubMed ID: 29437588
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Overall survival benefit of symptom monitoring in real-world patients with chronic lymphocytic leukaemia treated with ibrutinib: a FiLO group study.
    Ysebaert L; Quinquenel A; Bijou F; Ferrant E; Michallet AS;
    Eur J Cancer; 2020 Aug; 135():170-172. PubMed ID: 32585590
    [No Abstract]   [Full Text] [Related]  

  • 51. Treatment and outcomes of invasive fusariosis: review of 65 cases from the PATH Alliance(®) registry.
    Horn DL; Freifeld AG; Schuster MG; Azie NE; Franks B; Kauffman CA
    Mycoses; 2014 Nov; 57(11):652-8. PubMed ID: 24943384
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Invasive aspergillosis caused by cryptic Aspergillus species: a report of two consecutive episodes in a patient with leukaemia.
    Peláez T; Álvarez-Pérez S; Mellado E; Serrano D; Valerio M; Blanco JL; Garcia ME; Muñoz P; Cuenca-Estrella M; Bouza E
    J Med Microbiol; 2013 Mar; 62(Pt 3):474-478. PubMed ID: 23161769
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hepatitis B Virus Reactivation under Ibrutinib Treatment in a Patient with Chronic Lymphocytic Leukemia.
    İskender G; İskender D; Ertek M
    Turk J Haematol; 2020 Aug; 37(3):208-209. PubMed ID: 32248674
    [No Abstract]   [Full Text] [Related]  

  • 54. ALK-positive histiocytosis associated with chronic lymphocytic leukaemia/small lymphocytic lymphoma: a multitarget response under ibrutinib.
    Syrykh C; Ysebaert L; Péricart S; Evrard SM; Meggetto F; Kanoun S; Brousset P; Laurent C
    Virchows Arch; 2021 Apr; 478(4):779-783. PubMed ID: 33011863
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Benefit of polyhexamethylene biguanide in Fusarium keratitis.
    Behrens-Baumann W; Seibold M; Hofmüller W; Walter S; Haeberle H; Wecke T; Tammer I; Tintelnot K
    Ophthalmic Res; 2012; 48(4):171-6. PubMed ID: 22710976
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment of non-Aspergillus moulds in immunocompromised patients, with amphotericin B lipid complex.
    Perfect JR
    Clin Infect Dis; 2005 May; 40 Suppl 6():S401-8. PubMed ID: 15809926
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Proven Invasive Pulmonary Aspergillosis in Stem Cell Transplant Recipient Due to Aspergillus sublatus, a Cryptic Species of A. nidulans.
    Chrenkova V; Hubka V; Cetkovsky P; Kouba M; Weinbergerova B; Lyskova P; Hornofova L; Hubacek P
    Mycopathologia; 2018 Apr; 183(2):423-429. PubMed ID: 29128933
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Invasive aspergillosis with pulmonary and central nervous system involvement during ibrutinib therapy for relapsed chronic lymphocytic leukaemia: case report.
    Peri AM; Bisi L; Cappelletti A; Colella E; Verga L; Borella C; Foresti S; Migliorino GM; Gori A; Bandera A
    Clin Microbiol Infect; 2018 Jul; 24(7):785-786. PubMed ID: 29427802
    [No Abstract]   [Full Text] [Related]  

  • 59. Fungal Keratitis: Epidemiology, Rapid Detection, and Antifungal Susceptibilities of
    Manikandan P; Abdel-Hadi A; Randhir Babu Singh Y; Revathi R; Anita R; Banawas S; Bin Dukhyil AA; Alshehri B; Shobana CS; Panneer Selvam K; Narendran V
    Biomed Res Int; 2019; 2019():6395840. PubMed ID: 30800674
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cerebral aspergillosis in a patient on ibrutinib therapy-A predisposition not to overlook.
    Faisal MS; Shaikh H; Khattab A; Albrethsen M; Fazal S
    J Oncol Pharm Pract; 2019 Sep; 25(6):1486-1490. PubMed ID: 30045683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.